We are live on
!
Find out more
EAM
Erste Asset Management Portfolio holdings
AUM
$12.9B
1-Year Est. Return
52.69%
This Fund
S&P 500
This Quarter
Est. Return
-16.19%
1 Year Est. Return
+52.69%
3 Year Est. Return
+142.55%
5 Year Est. Return
+182.36%
10 Year Est. Return
–
AUM
$1.49B
AUM Growth
–
Cap. Flow
+$1.64B
Cap. Flow
% of AUM
110.29%
Top 10 Holdings %
Top 10 Hldgs %
25.03%
Holding
443
New
443
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sarepta Therapeutics
SRPT
|
+$63.6M |
| 2 |
Microsoft
MSFT
|
+$62.3M |
| 3 |
CELG
Celgene Corp
CELG
|
+$52.1M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$37.9M |
| 5 |
Agios Pharmaceuticals
AGIO
|
+$34.5M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.02% |
| 2 | Technology | 21.31% |
| 3 | Consumer Discretionary | 14.52% |
| 4 | Financials | 8.82% |
| 5 | Communication Services | 6.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ICPT
201
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $1.3M | 0.09% |
+13,950
| New | +$1.45M |
|
202
Tesla
TSLA
$1.41T
| $1.28M | 0.09% |
+60,855
| New | +$1.31M |
|
|
XLRN
203
DELISTED
Acceleron Pharma
XLRN
| $1.27M | 0.09% |
+29,900
| New | +$1.49M |
|
204
Allstate
ALL
$65B
| $1.23M | 0.08% |
+15,000
| New | +$1.35M |
|
205
iShares MSCI Pacific ex Japan ETF
EPP
$2.25B
| $1.21M | 0.08% |
+29,730
| New | +$1.26M |
|
206
Bank of America
BAC
$416B
| $1.19M | 0.08% |
+48,680
| New | +$1.32M |
|
207
Enbridge
ENB
$106B
| $1.18M | 0.08% |
+38,924
| New | +$1.25M |
|
208
Western Digital
WDC
$149B
| $1.18M | 0.08% |
+42,336
| New | +$1.5M |
|
|
PETX
209
DELISTED
Aratana Therapeutics, Inc.
PETX
| $1.18M | 0.08% |
+200,000
| New | +$1.22M |
|
210
CSX Corp
CSX
$90.1B
| $1.18M | 0.08% |
+57,015
| New | +$1.31M |
|
211
Deere & Co
DE
$184B
| $1.14M | 0.08% |
+7,770
| New | +$1.14M |
|
|
CTXS
212
DELISTED
Citrix Systems Inc
CTXS
| $1.12M | 0.08% |
+11,000
| New | +$1.16M |
|
|
KDNY
213
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $1.12M | 0.08% |
+85,000
| New | +$1.7M |
|
214
Halozyme
HALO
$12.1B
| $1.12M | 0.08% |
+77,900
| New | +$1.24M |
|
215
Scotiabank
BNS
$114B
| $1.11M | 0.07% |
+22,200
| New | +$1.2M |
|
216
Infosys
INFY
$45.8B
| $1.09M | 0.07% |
+115,800
| New | +$1.11M |
|
|
NOAH
217
Noah Holdings
NOAH
$559M
| $1.07M | 0.07% |
+25,000
| New | +$1.04M |
|
218
GE Aerospace
GE
$319B
| $1.07M | 0.07% |
+30,578
| New | +$1.38M |
|
219
Kadant
KAI
$3.14B
| $1.06M | 0.07% |
+13,000
| New | +$1.22M |
|
220
Broadcom
AVGO
$1.62T
| $1.04M | 0.07% |
+41,550
| New | +$981K |
|
221
Intuitive Surgical
ISRG
$133B
| $1.04M | 0.07% |
+6,660
| New | +$1.13M |
|
|
JNCE
222
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $1.04M | 0.07% |
+310,100
| New | +$1.45M |
|
223
Canadian Imperial Bank of Commerce
CM
$103B
| $1.02M | 0.07% |
+27,400
| New | +$1.17M |
|
|
ZNGA
224
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $1.01M | 0.07% |
+260,000
| New | +$984K |
|
225
Essential Utilities
WTRG
$11.8B
| $1M | 0.07% |
+30,000
| New | +$1.04M |
|
Similar funds
FFA
GKIM
WI
CRM
PCM
BCI
VLKIM
BAMF
Erste Asset Management's Q4 2018 Portfolio in Review
Q4 2018 is the first quarter with a 13F filing on record for Erste Asset Management, which disclosed 443 positions worth $1.49B. Its ten largest holdings account for 25% of the portfolio.
Its largest position is Sarepta Therapeutics: 508,810 shares worth $54.8M.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, followed by Technology and Consumer Discretionary.
- Erste Asset Management's largest Q4 2018 buy was Sarepta Therapeutics: 508,810 shares worth $54.8M.
- Erste Asset Management's ten largest holdings make up 25% of its $1.49B portfolio in Q4 2018.
- Erste Asset Management disclosed 443 positions in Q4 2018, its first 13F filing on record.
Based on Erste Asset Management's 13F filing for Q4 2018, filed 26 Nov 2024.